Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring.
about
Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system.Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria.Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis.
P2860
Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Progression and remission of n ...... s of treatment and monitoring.
@en
type
label
Progression and remission of n ...... s of treatment and monitoring.
@en
prefLabel
Progression and remission of n ...... s of treatment and monitoring.
@en
P1476
Progression and remission of n ...... s of treatment and monitoring.
@en
P2093
Kasper Rossing
P577
2007-05-01T00:00:00Z